correlation and timing of *appearance* says it all and

New Post Public Reply Private Reply Replies (0) Message Board
4kids
473
correlation and timing of *appearance* says it all

and it's not unique to this SMB

the whining can be read by all with interest
and has been duly noted

flat out falsehood posts get deleted here
there is a site that welcomes them .. it isn't this one

lastly the negative focus on PTOI's historical documentation
as being an issue gives every indication
of trolling .. look it up .. as noted recently .. i liked it better
when .. had me on ignore .. vs the pretense of it

disputing factual data for the sake of *posting* is trolling
and it is always telling to me (and some others) as to why

NR and trading crews .. have always targeted factual historical data
but never more so until February 2010 .. when the DRS % link (implemented
at the behest of the SEC) via Finra first went live

for months *there* (2010) .. this very subject was verboten and posts
showing the DRS % on specific *OTC targets* were removed as OT
realize few OTC targets .. survive let alone outlast NRs' *efforts*

so NR and trading crews needed *new* talking points .. because for years these
entities' posted that there was no such thing as shorting OTC stocks


coincidentally the author of PTOI's first hit piece spread this bogus bs at every turn

of course back then (due to P2O's actual investors vs those who trade and were loosely affiliated with the *original* trading crew embedded in P2O since 2009) the usual by rote working of a stock was to cycle up .. cycle back .. cycle up .. cycle back

with P2O's founder having actual investors (to this day many of whom have never sold one share) .. the by rote conditioning of certain *original* NR trading crews' posting on P2O's SMB .. had little effect .. which is why NR was so significantly upside down from the *hand off* of December 2009 into January 2010

by the EO December 2010 .. NR was significantly *stuck* (Upside Down) it's why in July of 2010 .. 2 separate *efforts* were undertaken by NR .. but the clutch move of September 2010 by NR was the set up for what would come to pass in 2011

in the meantime the founder of P2O .. would scale tech from table top to flagship in 4 years (2009 - 2013)

the easiest aspect NR controls on an OTC target is the PPS .. since 12/31/13 and 10/9/14 .. PTOI (the stock) has been held at or mostly below 10c and 5c respectively

again to point out what most can understand .. when investors actually sell .. volume increases .. it doesn't decrease

since P2O (the company) was wrested back in mid August 2013 .. PTOI's volume
has decreased YOY YTD .. with one exception .. 2018 .. PTOI had 13M and change go off .. slightly more (about 500,000 shares) than 2017's 13M and change

NR is beyond *stuck* on PTOI (the stock) .. NRs' MO is to always brutalize an UPSIDE DOWN OTC TARGET .. because it will always impact mgmt's ability to execute

over the coming days .. P2O will either file their annual (expense expended) or an NT indicating the intent by the company

or they won't

all the whining in the world on this board .. will not change what P2O's CEO & BoD
have scheduled

and no one here knows what is en route ..

the only aspect every *actual* P2O investor determines is whether they buy/sell or hold their PTOI *shares* .. (since it's clear by the always decreasing volume in play and what has had to be *marked* recently) it's equally clear that whomever tapped the *hidden* and non hidden volume of 1.29.19 .. it wasn't retail

so pointing out that PTOI's volume *imo* is being wash traded for volume maintenance

gets maligned consistently by *entities* .. most of whom are part of the original crew (both sides .. pro/con .. well covered .. there) embedded in P2O

so why exactly would that be .. it is crystal clear based on *volume* .. there are little to none news on P2O

and imo that will remain until the CEO & BoD .. actually give a reason for new eyes to enter .. which is as it should be

so it's not for new eyes ..

so ask yourself why the *crew* would have such an issue with historical/factual data re: PTOI?

it isn't rocket science .. but it is math

4kids











Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 545

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 791

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 526

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 129

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 188

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 190

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 138

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 40

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Volvo Ends LiDAR Partnership: What This Means for LAZR Stock

Updated Category News Views 315

Volvo's Shift Away from LiDAR Technology Recently, the Swedish automaker Volvo announced its decision to cease its partnership with Luminar Technologies Inc. (NASDAQ: LAZR). This bold move has caught the attention of the automotive industry, especially those tracking advancements in autonomous vehicle technology. By not integrating LiDAR technology into its forthcoming...

Continue Reading
Samsung and Xiaomi Face Antitrust Findings in India Market

Updated Category News Views 157

Samsung and Xiaomi Face Antitrust Investigation in India Samsung, Xiaomi, and various other smartphone manufacturers are under serious scrutiny for allegedly colluding with major e-commerce platforms in India, undermining fair market practices. The Competition Commission of India (CCI) has gathered evidence that suggests these companies coordinated with Amazon and...

Continue Reading
Bonnie Navin Honored as Top 25 Medical Malpractice Attorney

Updated Category News Views 164

Bonnie Navin Attributes and Accolades Bonnie Navin of Rubenstein Law has recently earned a significant honor by being selected as a member of the Medical Malpractice Trial Lawyers Association - Top 25. This elite recognition is awarded to the most distinguished attorneys specializing in medical malpractice across the nation, and it showcases Navin's exceptional skill and...

Continue Reading
Top Dividend Stocks for Long-Term Passive Income Investors

Updated Category News Views 99

Success in the business world has never been a cakewalk. Many new ventures stumble within a decade, and only a handful manage to stay afloat while also boasting a robust and growing dividend program. Companies that consistently dish out dividends reflect financial health, but there’s more to the story. Take Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE:...

Continue Reading
Cathie Wood Predicts Deflationary Boom Amid Market Decline

Updated Category News Views 404

Cathie Wood's Deflationary Boom Forecast Amid Market Turbulence CEO of Ark Funds, Cathie Wood, has made bold predictions regarding a potential "deflationary boom" despite significant losses in the stock market. Recent trading sessions saw renowned tech stocks, collectively known as the Magnificent Seven, lose about $780 billion in market capitalization in a single day,...

Continue Reading